Apitolisib-impurities | Pharmaffiliates

Apitolisib

Apitolisib is an orally administered therapy for the treatment of Solid Cancers, Breast Cancer, Prostate Cancer, Renal Cell Carcinoma, and Endometrial Carcinoma.Reference standards of Apitolisib API, and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.

stdClass Object
(
    [pname] => Apitolisib-API
    [catalogue_number] => PA 01 2740000
    [category_ids] => ,123,81,69,78,75,76,82,
    [chemical_name] => 
    [weight] => 498.61
    [form] => C23H30N8O3S
    [cas] => 1032754-93-0
    [pslug] => 1032754-93-0-apitolisib-pa012740000
    [latest_product] => 0
    [linkproducts] => 0
    [offers_id] => 
    [offers_name] => 
    [offers_status] => 
    [offers_start_date] => 
    [offers_end_date] => 
    [pageview] => 
    [offers_slug] => 
    [offers_product_id] => 
    [offers_product_code] => 
    [offers_master_id] => 
    [offer_percentage] => 
    [offers_product_main_cat] => 
)
PA 01 2740000

Apitolisib-API


  • Catalogue No.:PA 01 2740000

  • CAS :

    1032754-93-0

  • Molecular Formula : C23H30N8O3S

  • Molecular Weight : 498.61